Trial Outcomes & Findings for Effect of Injectable Platelet-Rich Fibrin (i-PRF) in Initial Treatment of Chronic Periodontitis (NCT NCT04178590)
NCT ID: NCT04178590
Last Updated: 2020-07-13
Results Overview
assessment of periodontal pocket depth by probing, mean value of periodontal pockets on one side of the jaw
COMPLETED
PHASE4
32 participants
baseline measure (before the intervention)
2020-07-13
Participant Flow
October 2019 Department of Periodontology and Oral Medicine School of Dental Medicine University of Belgrade
Periodontitis patients with systemic and/or other oral disease or ongoing drug therapy are excluded.
Unit of analysis: periodontal pockets
Participant milestones
| Measure |
All Study Participants
Study participants randomly assigned to receive two different treatments in cross - over study design: Scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin and Scaling and root planing in conjunction with saline
|
|---|---|
|
Overall Study
STARTED
|
32 64
|
|
Overall Study
COMPLETED
|
30 60
|
|
Overall Study
NOT COMPLETED
|
2 4
|
Reasons for withdrawal
| Measure |
All Study Participants
Study participants randomly assigned to receive two different treatments in cross - over study design: Scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin and Scaling and root planing in conjunction with saline
|
|---|---|
|
Overall Study
Pregnancy
|
1
|
|
Overall Study
Lost to Follow-up
|
1
|
Baseline Characteristics
unit was periodontal pocket - one side of the jaw (left or right), not whole patient
Baseline characteristics by cohort
| Measure |
All Study Participants
n=64 periodontal pocket
Study participants randomly assigned to receive two different treatments in cross- over study design : scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin and Scaling and root planing in conjunction with saline
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=32 Participants • unit was periodontal pocket - one side of the jaw (left or right), not whole patient
|
|
Age, Categorical
Between 18 and 65 years
|
32 Participants
n=32 Participants • unit was periodontal pocket - one side of the jaw (left or right), not whole patient
|
|
Age, Categorical
>=65 years
|
0 Participants
n=32 Participants • unit was periodontal pocket - one side of the jaw (left or right), not whole patient
|
|
Sex: Female, Male
Female
|
18 Participants
n=32 Participants • unit was periodontal pocket - one side of the jaw (left or right), not whole patient
|
|
Sex: Female, Male
Male
|
14 Participants
n=32 Participants • unit was periodontal pocket - one side of the jaw (left or right), not whole patient
|
|
Region of Enrollment
Serbia
|
32 participants
n=32 Participants • unit was periodontal pocket - one side of the jaw (left or right), not whole patient
|
|
mean value of periodontal pockets on one side of the jaw
|
32 periodontal pocket
STANDARD_DEVIATION 0 • n=64 periodontal pocket
|
PRIMARY outcome
Timeframe: baseline measure (before the intervention)assessment of periodontal pocket depth by probing, mean value of periodontal pockets on one side of the jaw
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Periodontal Pocket Depth-PPD
|
3.735 mm
Standard Deviation 0.863
|
3.696 mm
Standard Deviation 0.851
|
PRIMARY outcome
Timeframe: after 1 monthassessment of periodontal pocket depth by probing, mean value of periodontal pockets on one side of the jaw
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Periodontal Pocket Depth-PPD - 1m
|
2.398 mm
Standard Deviation 0.792
|
2.876 mm
Standard Deviation 0.804
|
PRIMARY outcome
Timeframe: after 3 monthsassessment of periodontal pocket depth by probing, mean value of periodontal pockets on one side of the jaw
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Periodontal Pocket Depth-PPD - 3m
|
1.990 mm
Standard Deviation 0.640
|
2.567 mm
Standard Deviation 0.701
|
PRIMARY outcome
Timeframe: after 6 monthsassessment of periodontal pocket depth by probing mean value of one side of the jaw
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Periodontal Pocket Depth-PPD - 6
|
1.778 mm
Standard Deviation 0.542
|
2.409 mm
Standard Deviation 0.640
|
PRIMARY outcome
Timeframe: baseline measure (before the intervention)assessment of level of gingival margin-LGM by probing, i.e.distance between cementoenamel junction and gingival margin (the most coronal point of the gingiva); mean value of one side of the jaw
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Level of Gingival Margin-LGM
|
1.737 mm
Standard Deviation 0.567
|
1.787 mm
Standard Deviation 0.589
|
PRIMARY outcome
Timeframe: after 1 monthassessment of level of gingival margin-LGM by probing, i.e.distance between cementoenamel junction and gingival margin (the most coronal point of the gingiva); mean value of one side of the jaw
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Level of Gingival Margin-LGM - 1m
|
0.948 mm
Standard Deviation 0.573
|
1.150 mm
Standard Deviation 0.462
|
PRIMARY outcome
Timeframe: after 3 monthsassessment of level of gingival margin-LGM by probing, i.e. distance between cementoenamel junction and gingival margin (the most coronal point of the gingiva); mean value of one side of the jaw
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Level of Gingival Margin-LGM - 3m
|
0.782 mm
Standard Deviation 0.580
|
0.877 mm
Standard Deviation 0.533
|
PRIMARY outcome
Timeframe: after 6 monthsassessment of level of gingival margin-LGM by probing, distance between cementoenamel junction and gingival margin (the most coronal point of the gingiva) after 6 months
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Level of Gingival Margin-LGM - 6m
|
0.808 mm
Standard Deviation 0.518
|
0.794 mm
Standard Deviation 0.457
|
PRIMARY outcome
Timeframe: baseline measure (before the intervention)assessment of clinical attachment level- CAL by probing
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Clinical Attachment Level- CAL
|
2.009 mm
Standard Deviation 0.724
|
2.018 mm
Standard Deviation 0.715
|
PRIMARY outcome
Timeframe: after 1 monthassessment of clinical attachment level- CAL by probing, mean value of one side of the jaw
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Clinical Attachment Level- CAL - 1m
|
1.453 mm
Standard Deviation 0.643
|
1.755 mm
Standard Deviation 0.654
|
PRIMARY outcome
Timeframe: after 3 monthsassessment of clinical attachment level- CAL by probing, mean value of one side of the jaw
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Clinical Attachment Level- CAL - 3m
|
1.237 mm
Standard Deviation 0.610
|
1.619 mm
Standard Deviation 0.618
|
PRIMARY outcome
Timeframe: after 6 monthsassessment of clinical attachment level- CAL by probing, mean value of one side of the jaw
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Clinical Attachment Level- CAL - 6m
|
1.226 mm
Standard Deviation 0.580
|
1.585 mm
Standard Deviation 0.619
|
PRIMARY outcome
Timeframe: baseline measure (before the intervention)assessment of bleeding on probing Mühlemann Papillary Bleeding Index , a four-grade index based on both the extent of bleeding and the time it takes for bleeding to occur after stimulation with a periodontal probe (0-the best outcome, 4-the worst outcome).
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Bleeding on Probing-BOP
|
1.418 score on a scale
Standard Deviation 0.714
|
1.345 score on a scale
Standard Deviation 0.711
|
PRIMARY outcome
Timeframe: after 1 monthassessment of bleeding on probing Mühlemann Papillary Bleeding Index , a four-grade index based on both the extent of bleeding and the time it takes for bleeding to occur after stimulation with a periodontal probe (0-the best outcome, 4-the worst outcome).
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Bleeding on Probing-BOP - 1m
|
0.649 score on a scale
Standard Deviation 0.454
|
1.005 score on a scale
Standard Deviation 0.562
|
PRIMARY outcome
Timeframe: after 3 monthsassessment of bleeding on probing Mühlemann Papillary Bleeding Index , a four-grade index based on both the extent of bleeding and the time it takes for bleeding to occur after stimulation with a periodontal probe (0-the best outcome, 4-the worst outcome).
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Bleeding on Probing-BOP 3m
|
0.298 score on a scale
Standard Deviation 0.280
|
0.601 score on a scale
Standard Deviation 0.392
|
PRIMARY outcome
Timeframe: after 6 monthsassessment of bleeding on probing Mühlemann Papillary Bleeding Index , a four-grade index based on both the extent of bleeding and the time it takes for bleeding to occur after stimulation with a periodontal probe (0-the best outcome, 4-the worst outcome).
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Bleeding on Probing-BOP - 6m
|
0.098 score on a scale
Standard Deviation 0.090
|
0.257 score on a scale
Standard Deviation 0.167
|
PRIMARY outcome
Timeframe: baseline measure (before the intervention)visual assessment of plaque index-PI and by probing Plaque Index (Silness and Löe), 0-the best outcome, 3-the worst outcome
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Plaque Index- PI
|
1.231 score on a scale
Standard Deviation 0.559
|
1.241 score on a scale
Standard Deviation 0.565
|
PRIMARY outcome
Timeframe: after 1 monthvisual assessment of plaque index-PI and by probing Plaque Index (Silness and Löe), 0-the best outcome, 3-the worst outcome
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Plaque Index- PI -1m
|
0.255 score on a scale
Standard Deviation 0.202
|
0.250 score on a scale
Standard Deviation 0.185
|
PRIMARY outcome
Timeframe: after 3 monthsvisual assessment of plaque index-PI and by probing Plaque Index (Silness and Löe), 0-the best outcome, 3-the worst outcome
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Plaque Index- PI -3m
|
0.236 score on a scale
Standard Deviation 0.254
|
0.212 score on a scale
Standard Deviation 0.182
|
PRIMARY outcome
Timeframe: after 6 monthsvisual assessment of plaque index-PI and by probing
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Plaque Index- PI - 6m
|
0.199 score on a scale
Standard Deviation 0.185
|
0.203 score on a scale
Standard Deviation 0.184
|
PRIMARY outcome
Timeframe: baseline measure (before the intervention)Number of periodontal pockets with presence/absence of Aggregatibacter actinomycetemcomitans in gingival crevicular fluid (GCF) at baseline
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Number of Periodontal Pockets With Presence/Absence of Aggregatibacter Actinomycetemcomitans (Aa) in Gingival Crevicular Fluid (GCF)
Presence of microorganism
|
24 GCF- periodontal pocket
|
24 GCF- periodontal pocket
|
|
Number of Periodontal Pockets With Presence/Absence of Aggregatibacter Actinomycetemcomitans (Aa) in Gingival Crevicular Fluid (GCF)
Absence of mimcroorganism
|
6 GCF- periodontal pocket
|
6 GCF- periodontal pocket
|
PRIMARY outcome
Timeframe: after 1 monthNumber of periodontal pockets with presence/absence of Aggregatibacter actinomycetemcomitans in gingival crevicular fluid (GCF) after 1 month
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Number of Periodontal Pockets With Presence/Absence of Aggregatibacter Actinomycetemcomitans (Aa) in Gingival Crevicular Fluid (GCF) -1m
Presence of microorganism
|
5 GCF- periodontal pocket
|
18 GCF- periodontal pocket
|
|
Number of Periodontal Pockets With Presence/Absence of Aggregatibacter Actinomycetemcomitans (Aa) in Gingival Crevicular Fluid (GCF) -1m
Absence of mimcroorganism
|
25 GCF- periodontal pocket
|
12 GCF- periodontal pocket
|
PRIMARY outcome
Timeframe: after 3 monthsNumber of periodontal pockets with presence/absence of Aggregatibacter Actinomycetemcomitans (Aa) in Gingival Crevicular Fluid (GCF) after 3 months
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Number of Periodontal Pockets With Presence/Absence of Aggregatibacter Actinomycetemcomitans (Aa) in Gingival Crevicular Fluid (GCF) - 3m
Presence of microorganism
|
8 GCF- periodontal pocket
|
16 GCF- periodontal pocket
|
|
Number of Periodontal Pockets With Presence/Absence of Aggregatibacter Actinomycetemcomitans (Aa) in Gingival Crevicular Fluid (GCF) - 3m
Absence of mimcroorganism
|
22 GCF- periodontal pocket
|
14 GCF- periodontal pocket
|
PRIMARY outcome
Timeframe: after 6 monthsNumber of periodontal pockets with presence/absence of Aggregatibacter actinomycetemcomitans in gingival crevicular fluid (GCF) after 6 months
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Number of Periodontal Pockets With Presence/Absence of Aggregatibacter Actinomycetemcomitans (Aa) in Gingival Crevicular Fluid (GCF) - 6m
Presence of microorganism
|
17 GCF- periodontal pocket
|
19 GCF- periodontal pocket
|
|
Number of Periodontal Pockets With Presence/Absence of Aggregatibacter Actinomycetemcomitans (Aa) in Gingival Crevicular Fluid (GCF) - 6m
Absence of mimcroorganism
|
13 GCF- periodontal pocket
|
11 GCF- periodontal pocket
|
PRIMARY outcome
Timeframe: baseline measure (before the intervention)Number of periodontal pockets with presence/absence of Porphyromonas gingivalis - Pg in gingival crevicular fluid (GCF) at baseline
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Number of Periodontal Pockets With Presence/Absence of Porphyromonas Gingivalis (Pg) in Gingival Crevicular Fluid (GCF)
Presence of microorganism
|
30 GCF- periodontal pocket
|
30 GCF- periodontal pocket
|
|
Number of Periodontal Pockets With Presence/Absence of Porphyromonas Gingivalis (Pg) in Gingival Crevicular Fluid (GCF)
Absence of mimcroorganism
|
0 GCF- periodontal pocket
|
0 GCF- periodontal pocket
|
PRIMARY outcome
Timeframe: after 1 monthNumber of periodontal pockets with presence/absence of Porphyromonas gingivalis - Pg in gingival crevicular fluid (GCF) after 1 month
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Number of Periodontal Pockets With Presence/Absence of Porphyromonas Gingivalis (Pg) in Gingival Crevicular Fluid (GCF) - 1m
Presence of microorganism
|
12 GCF- periodontal pocket
|
28 GCF- periodontal pocket
|
|
Number of Periodontal Pockets With Presence/Absence of Porphyromonas Gingivalis (Pg) in Gingival Crevicular Fluid (GCF) - 1m
Absence of mimcroorganism
|
18 GCF- periodontal pocket
|
2 GCF- periodontal pocket
|
PRIMARY outcome
Timeframe: after 3 monthsNumber of periodontal pockets with presence/absence of Porphyromonas gingivalis - Pg in gingival crevicular fluid after 3 months.
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Number of Periodontal Pockets With Presence/Absence of Porphyromonas Gingivalis (Pg) in Gingival Crevicular Fluid (GCF) - 3m
Presence of microorganism
|
21 GCF- periodontal pocket
|
27 GCF- periodontal pocket
|
|
Number of Periodontal Pockets With Presence/Absence of Porphyromonas Gingivalis (Pg) in Gingival Crevicular Fluid (GCF) - 3m
Absence of mimcroorganism
|
9 GCF- periodontal pocket
|
3 GCF- periodontal pocket
|
PRIMARY outcome
Timeframe: after 6 monthsNumber of periodontal pockets with presence/absence of Porphyromonas gingivalis - Pg in gingival crevicular fluid after 6 months.
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Number of Periodontal Pockets With Presence/Absence of Porphyromonas Gingivalis (Pg) in Gingival Crevicular Fluid (GCF) - 6m
Absence of mimcroorganism
|
2 GCF- periodontal pocket
|
1 GCF- periodontal pocket
|
|
Number of Periodontal Pockets With Presence/Absence of Porphyromonas Gingivalis (Pg) in Gingival Crevicular Fluid (GCF) - 6m
Presence of microorganism
|
28 GCF- periodontal pocket
|
29 GCF- periodontal pocket
|
PRIMARY outcome
Timeframe: baseline measure (before the intervention)Number of periodontal pockets with presence/absence of Prevotella intermedia-Pi in gingival crevicular fluid (GCF) at baseline
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Number of Periodontal Pockets With Presence/Absence of Prevotella Intermedia (Pi) in Gingival Crevicular Fluid (GCF)
Presence of microorganism
|
27 GCF- periodontal pocket
|
27 GCF- periodontal pocket
|
|
Number of Periodontal Pockets With Presence/Absence of Prevotella Intermedia (Pi) in Gingival Crevicular Fluid (GCF)
Absence of mimcroorganism
|
3 GCF- periodontal pocket
|
3 GCF- periodontal pocket
|
PRIMARY outcome
Timeframe: after 1 monthNumber of periodontal pockets with presence/absence of Prevotella intermedia-Pi in gingival crevicular fluid (GCF) after 1 month.
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Number of Periodontal Pockets With Presence/Absence of Prevotella Intermedia (Pi) in Gingival Crevicular Fluid (GCF) -1m
Presence of microorganism
|
12 GCF- periodontal pocket
|
23 GCF- periodontal pocket
|
|
Number of Periodontal Pockets With Presence/Absence of Prevotella Intermedia (Pi) in Gingival Crevicular Fluid (GCF) -1m
Absence of mimcroorganism
|
18 GCF- periodontal pocket
|
7 GCF- periodontal pocket
|
PRIMARY outcome
Timeframe: after 3 monthsNumber of periodontal pockets with presence/absence of Prevotella intermedia-Pi in gingival crevicular fluid (GCF) after 3 months.
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Number of Periodontal Pockets With Presence/Absence of Prevotella Intermedia (Pi) in Gingival Crevicular Fluid (GCF) - 3m
Presence of microorganism
|
17 GCF- periodontal pocket
|
20 GCF- periodontal pocket
|
|
Number of Periodontal Pockets With Presence/Absence of Prevotella Intermedia (Pi) in Gingival Crevicular Fluid (GCF) - 3m
Absence of mimcroorganism
|
13 GCF- periodontal pocket
|
10 GCF- periodontal pocket
|
PRIMARY outcome
Timeframe: after 6 monthsNumber of periodontal pockets with presence/absence of Prevotella intermedia-Pi in gingival crevicular fluid (GCF) after 6 months.
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Number of Periodontal Pockets With Presence/Absence of Prevotella Intermedia (Pi) in Gingival Crevicular Fluid (GCF) -6m
Presence of microorganism
|
22 GCF- periodontal pocket
|
24 GCF- periodontal pocket
|
|
Number of Periodontal Pockets With Presence/Absence of Prevotella Intermedia (Pi) in Gingival Crevicular Fluid (GCF) -6m
Absence of mimcroorganism
|
8 GCF- periodontal pocket
|
6 GCF- periodontal pocket
|
PRIMARY outcome
Timeframe: baseline measure (before the intervention)Number of periodontal pockets with presence/absence of Tannerella forsythia-Tf in gingival crevicular fluid (GCF) at baseline
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Number of Periodontal Pockets With Presence/Absence of Tannerella Forsythia (Tf) in Gingival Crevicular Fluid (GCF)
Presence of microorganism
|
24 GCF- periodontal pocket
|
24 GCF- periodontal pocket
|
|
Number of Periodontal Pockets With Presence/Absence of Tannerella Forsythia (Tf) in Gingival Crevicular Fluid (GCF)
Absence of mimcroorganism
|
6 GCF- periodontal pocket
|
6 GCF- periodontal pocket
|
PRIMARY outcome
Timeframe: after 1 monthNumber of periodontal pockets with presence/absence of Tannerella forsythia-Tf in gingival crevicular fluid (GCF) after 1 month.
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Number of Periodontal Pockets With Presence/Absence of Tannerella Forsythia (Tf) in Gingival Crevicular Fluid (GCF) - 1m
Absence of mimcroorganism
|
23 GCF- periodontal pocket
|
7 GCF- periodontal pocket
|
|
Number of Periodontal Pockets With Presence/Absence of Tannerella Forsythia (Tf) in Gingival Crevicular Fluid (GCF) - 1m
Presence of microorganism
|
7 GCF- periodontal pocket
|
23 GCF- periodontal pocket
|
PRIMARY outcome
Timeframe: after 3 monthsNumber of periodontal pockets with presence/absence of Tannerella forsythia-Tf in gingival crevicular fluid (GCF) after 3 months.
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Number of Periodontal Pockets With Presence/Absence of Tannerella Forsythia (Tf) in Gingival Crevicular Fluid (GCF) - 3m
Presence of microorganism
|
11 GCF- periodontal pocket
|
24 GCF- periodontal pocket
|
|
Number of Periodontal Pockets With Presence/Absence of Tannerella Forsythia (Tf) in Gingival Crevicular Fluid (GCF) - 3m
Absence of mimcroorganism
|
19 GCF- periodontal pocket
|
6 GCF- periodontal pocket
|
PRIMARY outcome
Timeframe: after 6 monthsNumber of periodontal pockets with presence/absence of Tannerella forsythia-Tf in gingival crevicular fluid (GCF) after 6 months.
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Number of Periodontal Pockets With Presence/Absence of Tannerella Forsythia (Tf) in Gingival Crevicular Fluid (GCF) - 6m
Presence of microorganism
|
17 GCF- periodontal pocket
|
24 GCF- periodontal pocket
|
|
Number of Periodontal Pockets With Presence/Absence of Tannerella Forsythia (Tf) in Gingival Crevicular Fluid (GCF) - 6m
Absence of mimcroorganism
|
13 GCF- periodontal pocket
|
6 GCF- periodontal pocket
|
PRIMARY outcome
Timeframe: baseline measure (before the intervention)The concentration of periodontal pocket microorganisms determined in gingival crevicular fluid (GCF) by qPCR-real time.
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Periodontal Pocket Microorganisms
|
2408369.00 copy number
Standard Deviation 3488796.726
|
2372881.00 copy number
Standard Deviation 3483340.472
|
PRIMARY outcome
Timeframe: after 1 monthThe concentration of periodontal pocket microorganisms determined in gingival crevicular fluid (GCF) by qPCR-real time after 1 month.
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Periodontal Pocket Microorganisms -1m
|
27708.86 copy number
Standard Deviation 60036.838
|
323142 copy number
Standard Deviation 458640
|
PRIMARY outcome
Timeframe: after 3 monthsThe concentration of periodontal pocket microorganisms determined in gingival crevicular fluid (GCF) by qPCR-real time after 3 months.
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Periodontal Pocket Microorganisms - 3m
|
825098.93 copy number
Standard Deviation 4246296.647
|
226048.10 copy number
Standard Deviation 680604
|
PRIMARY outcome
Timeframe: after 6 monthsThe concentration of periodontal pocket microorganisms determined in gingival crevicular fluid (GCF) by qPCR-real time after 6 months.
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Periodontal Pocket Microorganisms - 6m
|
71493.73 copy number
Standard Deviation 95627.954
|
336812.27 copy number
Standard Deviation 1057691
|
PRIMARY outcome
Timeframe: baseline measure (before the intervention)concentration of Tumor necrosis factor alpha-TNF-α in GCF using ELISA Kit
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Tumor Necrosis Factor Alpha-TNF-α
|
0.925 pg/µl
Standard Deviation 0.109
|
0.918 pg/µl
Standard Deviation 0.105
|
PRIMARY outcome
Timeframe: after 1 monthThe concentration of Tumor necrosis factor alpha-TNF-α in GCF using ELISA Kit
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Tumor Necrosis Factor Alpha-TNF-α -1m
|
0.382 pg/µl
Standard Deviation 0.040
|
0.782 pg/µl
Standard Deviation 0.092
|
PRIMARY outcome
Timeframe: after 3 monthsThe concentration of Tumor necrosis factor alpha-TNF-α using ELISA Kit after 3 months.
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Tumor Necrosis Factor Alpha-TNF-α - 3m
|
0.259 pg/µl
Standard Deviation 0.040
|
0.587 pg/µl
Standard Deviation 0.104
|
PRIMARY outcome
Timeframe: after 6 monthsThe concentration of Tumor necrosis factor alpha-TNF-α using ELISA Kit after 6 months.
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Tumor Necrosis Factor Alpha-TNF-α -6m
|
0.238 pg/µl
Standard Deviation 0.034
|
0.456 pg/µl
Standard Deviation 0.072
|
PRIMARY outcome
Timeframe: baseline measure (before the intervention)The concentration of Matrix metalloproteinase 8 - MMP-8 in GCF using ELISA Kit
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Matrix Metalloproteinase 8 - MMP-8
|
11.315 pg/ml
Standard Deviation 1.741
|
11.336 pg/ml
Standard Deviation 1.720
|
PRIMARY outcome
Timeframe: after 1 monthThe concentration of Matrix metalloproteinase 8 - MMP-8 in GCF using ELISA Kit after 1 month.
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Matrix Metalloproteinase 8 - MMP-8 -1m
|
7.906 pg/ml
Standard Deviation 1.356
|
9.964 pg/ml
Standard Deviation 1.488
|
PRIMARY outcome
Timeframe: after 3 monthsThe concentration of Matrix metalloproteinase 8 - MMP-8 using ELISA Kit after 3 months.
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Matrix Metalloproteinase 8 - MMP-8 - 3m
|
6.010 pg/ml
Standard Deviation 1.357
|
9.061 pg/ml
Standard Deviation 1.364
|
PRIMARY outcome
Timeframe: after 6 monthsThe concentration of Matrix metalloproteinase 8 - MMP-8 using ELISA Kit after 6 months.
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Matrix Metalloproteinase 8 - MMP-8 - 6m
|
4.681 pg/ml
Standard Deviation 1.465
|
8.642 pg/ml
Standard Deviation 1.303
|
PRIMARY outcome
Timeframe: baseline measure (before the intervention)The concentration of Alkaline phosphatase - ALP in GCF using ELISA Kit
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Alkaline Phosphatase - ALP
|
280.496 pg/ml
Standard Deviation 95.941
|
280.852 pg/ml
Standard Deviation 96.263
|
PRIMARY outcome
Timeframe: after 1 monthThe concentration of Alkaline phosphatase - ALP in GCF using ELISA Kit after 1 month.
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Alkaline Phosphatase - ALP -1m
|
116.936 pg/ml
Standard Deviation 37.529
|
199.666 pg/ml
Standard Deviation 76.413
|
PRIMARY outcome
Timeframe: after 3 monthsThe concentration of Alkaline phosphatase - ALP using ELISA Kitafter 3 months.
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Alkaline Phosphatase - ALP -3m
|
145.716 pg/ml
Standard Deviation 49.959
|
216.835 pg/ml
Standard Deviation 79.486
|
PRIMARY outcome
Timeframe: after 6 monthsThe concentration of Alkaline phosphatase - ALP using ELISA Kit after 6 months.
Outcome measures
| Measure |
SRP + Injectable Platelet-Rich Fibrin
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with Injectable Platelet-Rich Fibrin
|
SRP + Placebo
n=30 GCF- periodontal pocket
The side of the mouth which will be treated with scaling and root planing in conjunction with saline
|
|---|---|---|
|
Alkaline Phosphatase - ALP -6m
|
237.554 pg/ml
Standard Deviation 79.872
|
268.905 pg/ml
Standard Deviation 90.331
|
Adverse Events
SRP + Injectable Platelet-Rich Fibrin
SRP + Placebo
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr Mila Vuckovic
Department of Periodontology and Oral Medicine, School of Dental Medicine, University of Belgrade
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place